Results 191 to 200 of about 2,479 (207)

Erenumab/fremanezumab/galcanezumab

Reactions Weekly
openaire   +2 more sources

<p>Fremanezumab in the treatment of migraines: evidence to date</p>

Journal of Pain Research, 2019
Jennifer V Robblee, Juliana Vanderpluym
exaly  

Fremanezumab

Reactions Weekly
openaire   +1 more source

Fremanezumab/methotrexate

Reactions Weekly
openaire   +1 more source

Baloxavir marboxil, Fremanezumab-vfrm, Galcanezumab-gnlm, and Lofexidine hydrochloride

Journal of the American Pharmacists Association, 2019
Daniel A, Hussar, Matthew R, Moyer
openaire   +2 more sources

Erenumab/Fremanezumab

Reactions Weekly
openaire   +1 more source

Wirksamkeit des CGRP-Antikörpers Fremanezumab erneut bestätigt

InFo Neurologie + Psychiatrie, 2020
openaire   +1 more source

A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects

Cephalalgia, 2018
exaly  

Fremanezumab erreicht alle Phase-IIIb-Endpunkte

DNP - Der Neurologe & Psychiater, 2019
openaire   +1 more source

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine

Headache, 2019
exaly